- Vitafy Brands merges with EVP Group, taking an important step towards international expansion and brick-and-mortar retailing
- Private equity firm capiton supports the newly formed group as main investor
- Eight Advisory supported Vitafy Brands with sell & buy side due diligence in the transaction
Vitafy GmbH, founded in Munich in 2014, specializes in developing and offering OTC products, i.e. non-prescription drugs, as well as nutrition products for health-oriented customers. Due to several acquisitions, the company has developed into a leading D2C online platform in the healthcare sector in recent years.
Vitafy benefits from special product development and marketing advantages through its direct access to consumers via its own branded online stores.
Through the merger, Vitafy, together with EVP Group, consolidates its position as a leading player in the European consumer healthcare market and enables further internal and acquisitive growth. With their main investor, private equity firm capiton, which will support the future buy-and-build activities with funding as well as know-how, the two experienced management teams of Vitafy and EVP aim to drive the new group forward as Europe’s leading vertically integrated multi-channel provider with comprehensive online and offline capabilities in consumer healthcare.
The parties have agreed not to disclose financial details of the transaction. Finally, the transaction is subject to antitrust clearance in Germany and abroad.
The advisory team around Marc Niclas, Partner (Lead/FDD, Munich) and Jan Ole Burchert (TDD, Frankfurt), consisted of Manuel Wall (TDD, Frankfurt), Heloise Campos (FDD, Munich), Henrik Merz (FDD, Frankfurt), Taron Hovhannissyan (FDD, Frankfurt), Ismail Kacmaz (FDD, Munich) as well as Marco Benkert and Yannic Schott (both FDD, Munich).